Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ASND
Stock Latest News
The Fly
Ascendis Pharma price target raised to $246 from $242 at BofA
2d ago
ASND
Premium
Company Announcements
Ascendis Pharma Sets 2026 Milestones and Unveils $120 Million Share Buyback
2d ago
6K
ASND
Premium
The Fly
Ascendis Pharma sees FY25 revenue EUR 720M
4d ago
ASND
Premium
The Fly
Ascendis Pharma sees FY26 operating cash flow EUR 500M
4d ago
ASND
Premium
The Fly
Ascendis Pharma announces $120M share repurchase program
4d ago
ASND
Premium
Ratings
Ascendis Pharma: TransCon CNP/hGH Combo Data De-Risk Achondroplasia Program and Support Higher Target Price and Buy Rating
5d ago
ASND
Premium
The Fly
Ascendis Pharma price target raised to $322 from $297 at Wells Fargo
5d ago
ASND
Premium
Company Announcements
Ascendis Pharma Posts Strong Year-Long Phase 2 COACH Data for TransCon CNP and hGH Combo in Achondroplasia
5d ago
6K
ASND
Premium
Ratings
Ascendis Pharma: Advancing Achondroplasia Combo Franchise and De-Risked Regulatory Path Support Buy Rating and $242 Target
5d ago
ASND
Premium
The Fly
Ascendis Pharma announces topline results from Week 52 of COACH trial
5d ago
ASND
Premium
Company Announcements
Ascendis Pharma Advances Weekly Skytrofa Trial in Pediatric Growth Disorders: What Investors Should Watch
7d ago
ASND
Premium
Ratings
TD Cowen Analyst Highlights Ascendis Pharma as Priority Healthcare Name With Buy Rating and Expected Outperformance
7d ago
ASND
Premium
Company Announcements
Ascendis Pharma Ups Share Capital After Warrant Exercises in December 2025
14d ago
6K
ASND
Premium
The Fly
Ascendis Pharma rumor highlighted in Betaville blog
1M ago
ASND
Premium
The Fly
Ascendis Pharma price target raised to $256 from $254 at Stifel
1M ago
ASND
Premium
Company Announcements
Ascendis Pharma Grants Employee Warrants to Strengthen Market Position
1M ago
6K
ASND
Premium
Ratings
Positive Outlook for Ascendis Pharma: Buy Rating Despite PDUFA Delay
2M ago
ASND
Premium
Company Announcements
Ascendis Pharma Faces FDA Delay for TransCon CNP Approval
2M ago
6K
ASND
Premium
Ratings
Positive Outlook on Ascendis Pharma Despite PDUFA Date Extension for TransCon CNP
2M ago
ASND
Premium
The Fly
Ascendis Pharma annouces FDA extension for TransCon CN
2M ago
ASND
Premium
Market News
FDA Calendar: These Are the Upcoming FDA Drug Approvals
2M ago
ASND
KURA
Premium
Ratings
Buy Rating for Ascendis Pharma Driven by Promising TransCon CNP Developments in Achondroplasia Treatment
2M ago
ASND
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
